GLPG CAR T-cell therapy

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesNCT06652633LKFTPhase 3Recruiting2039-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.